메뉴 건너뛰기




Volumn 21, Issue 123, 2012, Pages 6-7

How can we reduce the mortality of invasive pneumococcal disease?

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

EID: 84857834054     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00000312     Document Type: Editorial
Times cited : (6)

References (11)
  • 1
    • 84857872351 scopus 로고    scopus 로고
    • The remaining challenges of pneumococcal disease in adults
    • Ludwig E, Bonanni P, Rohde G, et al. The remaining challenges of pneumococcal disease in adults. Eur Respir Rev 2012; 21: 57-65.
    • (2012) Eur Respir Rev , vol.21 , pp. 57-65
    • Ludwig, E.1    Bonanni, P.2    Rohde, G.3
  • 2
    • 70350498834 scopus 로고    scopus 로고
    • Pathogenesis, treatment, and prevention of pneumococcal pneumonia
    • van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543-1556.
    • (2009) Lancet , vol.374 , pp. 1543-1556
    • van der Poll, T.1    Opal, S.M.2
  • 4
    • 84855204394 scopus 로고    scopus 로고
    • Clinical and economic burden of community-acquired pneumonia among adults in Europe
    • Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67: 71-79.
    • (2012) Thorax , vol.67 , pp. 71-79
    • Welte, T.1    Torres, A.2    Nathwani, D.3
  • 5
    • 0043269792 scopus 로고    scopus 로고
    • An international prospective study of pneumococcal bacteremia: Correlation with in vitro resistance, antibiotics administered, and clinical outcome
    • Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37: 230-237.
    • (2003) Clin Infect Dis , vol.37 , pp. 230-237
    • Yu, V.L.1    Chiou, C.C.2    Feldman, C.3
  • 6
    • 33750346251 scopus 로고    scopus 로고
    • Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumo-coccal disease: A matched case-control study
    • Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumo-coccal disease: a matched case-control study. Lancet 2006; 368: 1495-1502.
    • (2006) Lancet , vol.368 , pp. 1495-1502
    • Whitney, C.G.1    Pilishvili, T.2    Farley, M.M.3
  • 7
    • 46249112163 scopus 로고    scopus 로고
    • Pneumococcal vaccines: Mechanism of action, impact on epidemiology and adaption of the species
    • Pletz MW, Maus U, Krug N, et al. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008; 32: 199-206.
    • (2008) Int J Antimicrob Agents , vol.32 , pp. 199-206
    • Pletz, M.W.1    Maus, U.2    Krug, N.3
  • 8
    • 77952300034 scopus 로고    scopus 로고
    • The effect of age on the response to the pneumococcal polysaccharide vaccine
    • Lee H, Nahm MH, Kim KH. The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect Dis 2010; 10: 60.
    • (2010) BMC Infect Dis , vol.10 , pp. 60
    • Lee, H.1    Nahm, M.H.2    Kim, K.H.3
  • 9
    • 55049089930 scopus 로고    scopus 로고
    • Rationale and design of CAPITA: A RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults
    • Hak E, Grobbee DE, Sanders EA, et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008; 66: 378-383.
    • (2008) Neth J Med , vol.66 , pp. 378-383
    • Hak, E.1    Grobbee, D.E.2    Sanders, E.A.3
  • 10
    • 42549087356 scopus 로고    scopus 로고
    • Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: Conjugate vaccine elicits improved antibacterial immune responses and immunological memory
    • de Roux A, Schmöle-Thoma B, Siber GR, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008; 46: 1015-1023.
    • (2008) Clin Infect Dis , vol.46 , pp. 1015-1023
    • de Roux, A.1    Schmöle-Thoma, B.2    Siber, G.R.3
  • 11
    • 77749316814 scopus 로고    scopus 로고
    • Increased risk of hospitali-zation for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: A cohort study
    • O'Grady KA, Lee KJ, Carlin JB, et al. Increased risk of hospitali-zation for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study. Clin Infect Dis 2010; 50: 970-978.
    • (2010) Clin Infect Dis , vol.50 , pp. 970-978
    • O'Grady, K.A.1    Lee, K.J.2    Carlin, J.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.